|
Name |
xylarenone A, (rel)-
|
Molecular Formula | C15H20O4 | |
IUPAC Name* |
(1aR,4R,7S,7aR,7bR)-4-hydroxy-1a-(3-hydroxyprop-1-en-2-yl)-7,7a-dimethyl-5,6,7,7b-tetrahydro-4H-naphtho[1,2-b]oxiren-2-one
|
|
SMILES |
C[C@H]1CC[C@H](C2=CC(=O)[C@]3([C@@H]([C@]12C)O3)C(=C)CO)O
|
|
InChI |
InChI=1S/C15H20O4/c1-8-4-5-11(17)10-6-12(18)15(9(2)7-16)13(19-15)14(8,10)3/h6,8,11,13,16-17H,2,4-5,7H2,1,3H3/t8-,11+,13+,14+,15-/m0/s1
|
|
InChIKey |
PSGJCHLXOJTCGB-SXHPEXCUSA-N
|
|
Synonyms |
xylarenone A, (rel)-; Xylarenone A; CHEBI:69731; CHEMBL1813182; Q27138076; (1aR,4R,7S,7aR,7bR)-4-hydroxy-1a-(3-hydroxyprop-1-en-2-yl)-7,7a-dimethyl-5,6,7,7b-tetrahydro-4H-naphtho[1,2-b]oxiren-2-one
|
|
CAS | NA | |
PubChem CID | 24752810 | |
ChEMBL ID | CHEMBL1813182 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 264.32 | ALogp: | 0.7 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 70.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 19 | QED Weighted: | 0.584 |
Caco-2 Permeability: | -4.754 | MDCK Permeability: | 0.00002870 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.427 |
30% Bioavailability (F30%): | 0.006 |
Blood-Brain-Barrier Penetration (BBB): | 0.933 | Plasma Protein Binding (PPB): | 37.84% |
Volume Distribution (VD): | 0.588 | Fu: | 74.06% |
CYP1A2-inhibitor: | 0.011 | CYP1A2-substrate: | 0.818 |
CYP2C19-inhibitor: | 0.016 | CYP2C19-substrate: | 0.812 |
CYP2C9-inhibitor: | 0.006 | CYP2C9-substrate: | 0.035 |
CYP2D6-inhibitor: | 0.002 | CYP2D6-substrate: | 0.211 |
CYP3A4-inhibitor: | 0.021 | CYP3A4-substrate: | 0.516 |
Clearance (CL): | 4.181 | Half-life (T1/2): | 0.949 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.22 |
Drug-inuced Liver Injury (DILI): | 0.19 | AMES Toxicity: | 0.973 |
Rat Oral Acute Toxicity: | 0.857 | Maximum Recommended Daily Dose: | 0.433 |
Skin Sensitization: | 0.745 | Carcinogencity: | 0.323 |
Eye Corrosion: | 0.146 | Eye Irritation: | 0.554 |
Respiratory Toxicity: | 0.834 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005060 | 0.578 | D08PIQ | 0.265 | ||||
ENC002770 | 0.506 | D07DVK | 0.260 | ||||
ENC002779 | 0.495 | D03IKT | 0.260 | ||||
ENC002780 | 0.484 | D0CW1P | 0.260 | ||||
ENC004560 | 0.342 | D0IT2G | 0.260 | ||||
ENC004555 | 0.338 | D0D1SG | 0.258 | ||||
ENC004784 | 0.313 | D0KR5B | 0.258 | ||||
ENC005062 | 0.311 | D04VIS | 0.253 | ||||
ENC001526 | 0.297 | D0I5DS | 0.253 | ||||
ENC003344 | 0.294 | D0R7JT | 0.253 |